<H2> Description </H2>

<P>This track shows probable binding sites of the specified transcription
factors (TFs) in the given cell types as determined by chromatin
immunoprecipitation followed by high throughput sequencing (ChIP-Seq).
Included for each cell type is the input signal, which represents the control
condition where no antibody targeting was performed.
For each experiment (cell type vs. antibody) this track shows
a graph of enrichment for TF binding (<I>Signal</I>), along with
sites that have the greatest evidence of transcription factor binding (<I>Peaks</I>).
<P>
The sequence reads, quality scores, and alignment coordinates from
these experiments are available for download.
</P>

<H2> Display Conventions and Configuration </H2>
<P>
This track is a multi-view composite track that contains multiple data types
(<EM>views</EM>).  For each view, there are multiple subtracks that
display individually on the browser.  Instructions for configuring multi-view
tracks are <A HREF="../../goldenPath/help/multiView.html" TARGET=_BLANK>here</A>.
ENCODE tracks typically contain one or more of the following views:
<DL>
<DT><I>Peaks</I></DT><DD> Regions of signal enrichment based on processed data
(usually normalized data from pooled replicates). ENCODE Peaks tables contain
fields for statistical significance, including FDR
(<A HREF="../../goldenPath/help/qValue.html" TARGET=_BLANK>qValue</A>).</DD>
<DT><I>Signal</I></DT><DD>Density graph (wiggle) of signal enrichment based on
processed data.</DD>
</DL>

<H2> Methods </H2>
<P>
Cells were grown according to the approved
<A HREF="../../ENCODE/protocols/cell" TARGET=_BLANK>ENCODE cell culture protocols</A>.
Further preparations were similar to those previously published
(Euskirchen <EM>et al.</EM>, 2007) with the exceptions that the cells
were unstimulated and sodium orthovanadate was omitted from the buffers.
For details on the chromatin immunoprecipitation protocol used, see
Euskirchen <EM>et al.</EM> (2007) and Rozowsky <EM>et al.</EM> (2009).
</P>
<P>
DNA recovered from the precipitated chromatin was sequenced on the Illumina (Solexa)
sequencing platform and mapped to the genome using the Eland alignment program.
ChIP-seq data was scored based on sequence reads (length ~30 bps) that align uniquely
to the human genome. From the mapped tags a signal map of ChIP DNA fragments
(average fragment length ~ 200 bp) was constructed where the signal height is the number of
overlapping fragments at each nucleotide position in the genome.
</P>
<P>
For each 1 Mb segment of each chromosome a peak height threshold was
determined by requiring a false discovery rate &lt;= 0.05 when comparing the
number of peaks above threshold as compared the number obtained from multiple
simulations of a random null background with the same number of mapped
reads (also accounting for the fraction of mapable bases
for sequence tags in that 1 Mb segment). The number of mapped tags in a putative
binding region is compared to the normalized (normalized by correlating tag
counts
in genomic 10 kb windows) number of mapped tags in the same region from an input DNA control.
Using a binomial test, only regions that have a p-value &lt;= 0.05 are considered to be
significantly enriched compared to the input DNA control.
</P>

<H2> Credits </H2>
<P>These data were generated and analyzed by the labs of
<A HREF="http://snyderlab.stanford.edu/"
  class="external text" title="http://snyderlab.stanford.edu/"
  rel="nofollow" TARGET = _BLANK>Michael Snyder</a> at Stanford University;
<A HREF="http://bioinfo.mbb.yale.edu/"
  class="external text"
  title="http://bioinfo.mbb.yale.edu/" rel="nofollow"
  TARGET = _BLANK>Mark Gerstein</a> and
<A HREF="http://medicine.yale.edu/genetics/index.aspx"
  class="external text" title="http://medicine.yale.edu/genetics/index.aspx"
  rel="nofollow" TARGET = _BLANK>Sherman Weissman</a> at Yale University;
<A HREF="http://www.usc.edu/programs/pibbs/site/faculty/farnham_p.htm"
  class="external text" title="http://www.usc.edu/programs/pibbs/site/faculty/farnham_p.htm"
  rel="nofollow" TARGET = _BLANK>Peggy Farnham</a> at University of Southern California; and
<A HREF="http://struhl.med.harvard.edu/"
  class="external text" title="http://struhl.med.harvard.edu/"
  rel="nofollow" TARGET = _BLANK>Kevin Struhl</a> at Harvard.
&nbsp;&nbsp;
Contact: <A HREF="mailto:&#100;&#97;&#116;&#97;&#115;u&#98;&#109;&#105;&#115;&#115;i&#111;n&#64;&#103;&#101;r&#115;t&#101;&#105;n&#108;&#97;&#98;.&#111;&#114;&#103;"
  title="&#100;&#97;&#116;&#97;&#115;u&#98;&#109;&#105;&#115;&#115;i&#111;n&#64;&#103;&#101;r&#115;t&#101;&#105;n&#108;&#97;&#98;.&#111;&#114;&#103;" rel="nofollow"
  TARGET = _BLANK>&#100;&#97;&#116;&#97;&#115;u&#98;&#109;&#105;&#115;&#115;i&#111;n&#64;&#103;&#101;r&#115;t&#101;&#105;n&#108;&#97;&#98;.&#111;&#114;&#103;</a>.
<!-- above address is datasubmission at gersteinlab.org -->

</P>
<H2> References </H2>

<P>
Cao AR, Rabinovich, R, Xu M, Xu X, Jin VX, Farnham PJ. 
<A HREF="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069401/"
	class="external text"
	title="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069401/"
	rel="nofollow"
	TARGET = _BLANK>Genome-wide Analysis of Transcription Factor E2F1 Mutant Proteins Reveals That N- and C-terminal Protein Interaction Domains Do Not Participate in Targeting E2F1 to the Human Genome</A>.
<EM> J biol Chem.</EM> 2001 April 8; 286(14): 11985-11996
</P>

<P>
Euskirchen G, Royce TE, Bertone P, Martone R, Rinn JL, Nelson FK,
Sayward F, Luscombe NM, Miller P, Gerstein, M <EM>et al.</EM>
 <A HREF="http://mcb.asm.org/cgi/content/abstract/24/9/3804"
  class="external text"
  title="http://mcb.asm.org/cgi/content/abstract/24/9/3804"
  rel="nofollow" TARGET = _BLANK>CREB binds to multiple loci on human chromosome 22</A>.
 <em>Mol Cell Biol.</em> 2004 May;24(9):3804-14.
</P>

<P>
Euskirchen GM, Rozowsky JS, Wei C, Lee WH, Zhang ZD, Hartman S, Emanuelsson O,
Stolc V, Weissman S, Gerstein MB <EM>et al.</EM>
<A HREF="http://www.genome.org/cgi/content/abstract/17/6/898"
  CLASS="external text" title="http://www.genome.org/cgi/content/abstract/17/6/898"
  rel="nofollow" TARGET = _BLANK>Mapping of transcription factor binding
regions in mammalian cells by ChIP: comparison of array- and
sequencing-based technologies</A>.
<EM>Genome Res.</EM> 2007;17:898-909.
</P>

<P>
Iyengar s, Ivanov AV, Jin VX, Rauscher FJ 3rd, Farnham PJ.
<A HREF="http://www.ncbi.nlm.nih.gov/pubmed/21343339"
	class="external text"
	title="http://www.ncbi.nlm.nih.gov/pubmed/21343339"
	rel="nofollow"
	TARGET = _BLAN>Functional analysis of KAP1 genomic recruitment</A>.
<EM>Mol Cell Bio.</EM> 2001 May;31(9):1887-47.
</P>

<P>
Martone R, Euskirchen G, Bertone P, Hartman S, Royce TE, Luscombe NM,
Rinn JL, Nelson FK, Miller P, Gerstein M <EM>et al.</EM>
<A HREF="http://www.pnas.org/content/100/21/12247.abstract"
  class="external text" title="http://www.pnas.org/content/100/21/12247.abstract"
  rel="nofollow" TARGET = _BLANK> Distribution of NF-kappaB-binding sites across
human chromosome 22</A>.
<EM>Proc Natl Acad Sci USA.</EM> 2003 Oct;100(21):12247-52.
</P>

<P>
Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, Zeng T,
Euskirchen G, Bernier B, Varhol R, Delaney A <EM>et al.</EM>
<A HREF="http://www.nature.com/doifinder/10.1038/nmeth1068"
  class="external text"
  title="http://www.nature.com/doifinder/10.1038/nmeth1068" rel="nofollow"
   TARGET = _BLANK> Genome-wide profiles of STAT1 DNA association using
chromatin immunoprecipitation and massively parallel sequencing</A>.
<EM>Nat Methods.</EM> 2007;4:651-7.
</P>

<P>
Rozowsky J, Euskirchen G, Auerbach RK, Zhang ZD, Gibson T, Bjornson R,
Carriero N, Snyder M, Gerstein MB.
<A HREF="http://www.nature.com/nbt/journal/v27/n1/abs/nbt.1518.html"
  class="external text"
  title="http://www.nature.com/nbt/journal/v27/n1/abs/nbt.1518.html"
  rel="nofollow"
  TARGET = _BLANK> PeakSeq enables systematic scoring of ChIP-seq experiments
  relative to controls</A>.
 <EM>Nature Biotech.</EM> 2009;27:66-75.
</P>

<H2> Data Release Policy </H2>

<P>Data users may freely use ENCODE data, but may not, without prior
consent, submit publications that use an unpublished ENCODE dataset until
nine months following the release of the dataset.  This date is listed in
the <EM>Restricted Until</EM> column on the track configuration page and
the download page.  The full data release policy for ENCODE is available
<A HREF="../ENCODE/terms.html" TARGET=_BLANK>here</A>.</P>

